DUBLIN, Ireland: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Michael Arciero as Vice-President of Intellectual Property and Commercial Development. In the new role, Michael will oversee the intellectual property portfolio of the company and will […]
Genetics Research, LLC (“GR”), a privately-held company developing a portfolio of novel and proprietary CRISPR-associated technologies for targeted DNA enrichment, announced today that it has licensed certain of its patents relating to this technology to Oxford Nanopore Technologies, Ltd. (“Oxford Nanopore”) based in Oxford, United Kingdom. This license enables Oxford Nanopore to use GR patents […]
Expanding Bio-Techne’s lead in providing multi-omics research tools to co-detect RNA and protein targets MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ technology with release of the new RNA-Protein Co-Detection Assays. The RNAscope technology is an advanced in situ hybridization (ISH) assay that enables visualization of single-molecule […]
Cambridge, United Kingdom – Congenica, a digital health company enabling rapid and accurate analysis of complex genomic data, has launched a new module for its genomic analysis platform that will accelerate research into the relationship between an individual’s genomic variation and COVID-19 susceptibility, severity, and clinical outcomes. Since the beginning of the COVID-19 global pandemic outbreak, the […]
LONGMONT, Colo. — KromaTiD, Inc. today announced the appointment of Vic Myer to its Board of Directors. Dr. Myer joins KromaTiD’s Board with extensive experience in technology, R&D and pharmaceutical company executive leadership, including 5 years of experience as Chief Technology Officer of Editas Medicine, a leading developer of gene editing-based therapies. He is currently Entrepreneur in Residence […]
Total RNA is comprised of large amounts of undesired transcripts, such as ribosomal RNA (rRNA), which account for ~80-98 % of the total RNA sample, and globin mRNA, accounting for ~35-80 % of mRNA in blood samples. Therefore, RNA sample preparation for sequencings requires stringent rRNA and (for blood samples) globin depletion. The upgraded version […]
• Transaction strengthens QIAGEN’s leadership position in automated molecular testing • QIAGEN acquires remaining 80.1% stake in NeuMoDx Molecular, Inc. for $248 million • Medium- and high-throughput NeuMoDx automation solutions based on PCR testing technology to now be integrated into QIAGEN’s portfolio on a global basis • Menu of test solutions for infectious diseases – […]
Financing to support commercial launch of multiple “Powered by Cardea” product collaborations under the Cardea Innovation Partnership Program and accelerated growth of the Tech+Bio Infrastructure. SAN DIEGO — Cardea Bio Inc., who is integrating tiny bits of biology into modern electronics, via their Graphene-based Biology-gated Transistors (“Cardean Transistors™”), just announced the first closing in their […]
The new AutoGen vortex module upgrade enables a 35% improvement in throughput Holliston, MA: AutoGen Inc. is excited to announce the launch of the vortex module upgrade to their portfolio of FlexSTAR workflows. FlexSTAR workflows are fully automated instruments for isolating genomic DNA from large volumes of whole blood, buffy coats, saliva, cultured cells, and […]
CANCERPREV Cross-Disciplinary Program Expands Knowledge of Cancer Development to Deliver New Insights into Prevention Strategies Principal Focus on Advancing Understanding of Breast and Skin Cancer Risks SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced its participation in CANCERPREV, a research […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
